Effect of different hydration doses on renal function in patients with primary osteoporosis treated with zoledronic acid: A hospital-based retrospective cohort study.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
19 Jun 2020
19 Jun 2020
Historique:
entrez:
23
6
2020
pubmed:
23
6
2020
medline:
21
7
2020
Statut:
ppublish
Résumé
The objective was to investigate the association of different hydration doses and its effect on renal function in patients with primary osteoporosis treated with zoledronic acid.The subjects with primary osteoporosis treated with zoledronic acid at the First Affiliated Hospital of Chongqing Medical University, China, from January 2015 to December 2018 were included in this study. The subjects were classified according to different hydration doses. Renal function indexes before and after treatment were collected and adverse reactions recorded to analyze the changes in renal function associated with different hydration doses.The choice of the hydration dose treated with zoledronic acid deserves attention. The lower hydration dose is, the greater impact on renal function can be caused.
Identifiants
pubmed: 32569232
doi: 10.1097/MD.0000000000020831
pii: 00005792-202006190-00080
pmc: PMC7310907
doi:
Substances chimiques
Bone Density Conservation Agents
0
Rehydration Solutions
0
Zoledronic Acid
6XC1PAD3KF
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e20831Références
J Am Coll Cardiol. 2004 Oct 6;44(7):1393-9
pubmed: 15464318
Orthop Surg. 2017 Feb;9(1):103-109
pubmed: 28276638
J Clin Diagn Res. 2016 Jan;10(1):OC04-6
pubmed: 26894105
Eur J Vasc Endovasc Surg. 2018 Oct;56(4):497-506
pubmed: 29576336
Catheter Cardiovasc Interv. 2003 Jul;59(3):338-43
pubmed: 12822153
Br J Clin Pharmacol. 2017 Oct;83(10):2266-2273
pubmed: 28543687
J Bone Metab. 2017 Feb;24(1):37-49
pubmed: 28326300
Nephron Clin Pract. 2012;120(4):c179-84
pubmed: 22890468
Clin Chem. 1992 Oct;38(10):1933-53
pubmed: 1394976
Nat Rev Cardiol. 2016 Jan;13(1):28-35
pubmed: 26370473
Clin Rheumatol. 2010 Oct;29(10):1079-84
pubmed: 20544246
Osteoporos Int. 2014 Mar;25(3):1151-61
pubmed: 23974861
Toxicol In Vitro. 2008 Jun;22(4):899-909
pubmed: 18325729
Endokrynol Pol. 2014;65(2):96-104
pubmed: 24802732
Obstet Gynecol. 2009 Nov;114(5):999-1007
pubmed: 20168099
Am J Med. 1993 Jun;94(6):646-50
pubmed: 8506892
Hormones (Athens). 2009 Apr-Jun;8(2):96-110
pubmed: 19570737
Hemodial Int. 2010 Oct;14(4):348-54
pubmed: 20955269
J Crit Care. 2015 Aug;30(4):860.e7-13
pubmed: 25979272
Pharmacol Res. 2015 Sep;99:16-22
pubmed: 25976681
JACC Cardiovasc Interv. 2016 Jan 11;9(1):97-99
pubmed: 26685076